References
  1. Allemani C, Matsuda T, Di Carlo V, et al. Global survey of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancer from 322 population based registrations in 71 countries [J] Lancet, 2018, 391 (10125): 1023-1075. DOI: 10.1016/S0140-6736 (17) 33326-3
  2. LINDSAY K, SAKET R G. Treatment of Epithelial Ovarian Cancer [J] BMJ, 2020, 371
  3. Yang XW, Huang HX, Wang F, Zhou QL, Huang YQ, Qin RZ Elevated plasma CXCL12/SDF-1 levels are linked with disease severity of post menopausal osteoporosis Innate Immun 2020; 26:222-30
  4. Kurnit Katherine C, Fleming Gini F, Lengyel Ernst Updates and New Options in Advanced Epithelial Ovarian Cancer Treatment [J], 2021137 (1): 108-121
  5. Wang J, Liu TB, Yu LB, et al. Effect of Aidi injection on SKOV_3 human ovarian cancer cells [J]. Chinese Journal of Modern Medicine, 2011 (5):582-585.
  6. Liu Jie, Li Daorui, Chen Hao, et al. Cost-effectiveness analysis of Aidi injection combined with transcatheter arterial chemoembolization in the treatment of primary liver cancer [J]. Journal of Clinical Oncology, 2019, 24 (5):428-433.
  7. Yang Lingyan, Fan Huizhen. Research progress on the mechanism and clinical application of matrine and oxymatrine in the treatment of digestive system tumors [J]. Practical Clinical Medicine, 2016, 17 (5):97-100.
  8. Yang N, Han F, Cui H, et al. Matrine suppresses promotion and inducasapoptosis in human cholangiomocarcinoma cells through suppression of JAK2/STAT3 signaling Pharmacol Rep, 2015,67 (2): 388-393
  9. Wu J, Hu G, Dong Y, et al. Matrine indices Akt/mTOR signaling inhibition mediated autophagy and apoptosis in acute myeloid leukeemia cells J Cell Mol Med, 2017, 21 (6): 1171-1181
  10. Zhang J, Gao Y, Han H, et al. Matrine suppresses lung metastasis of human pathocellular cancer by directly targeting matrix metalloproteinase-9 BiochemBiophys Res Commun, 2019, 515 (1): 57-63
  11. Zhao XB, Qin Y, Niu YL, et al. Matrine inhibitors hypoxia/reoxygenation induced apoptosis of cardiovascular microvascular epithelial cells in rates via the JAK2/STAT3 signaling pathway Biomed Pharmaceutical, 2018, 106:117-124
  12. Chen Z, Nishimura N, Okamoto T, et al. Molecular Mechanismof Matrine from Sophora alopecuroides in the Reversing Effect of Multi Anticancer Drug Resistance in K562/ADR Cells Biomed Res Int, 2019, 2019:1269532
  13. Li T, Wong VK, Yi XQ, et al. Matrine induces cell anergy in human Jurkat T cells through modulation of mitogen activated protein kinases and nuclear factor of activated T cells signaling with concomitant up regulation of anergy associated genes expression Biol Pharm Bull, 2010, 33 (1): 40-46
  14. Monk BJ, et al. ATHENA-MONO (GOG-3020/ENGOT-ov45): A randomized, double blind, phase 3 trial evaluating rubarian monotherapy versus placebo as maintenance treatment following response to first line platinum based chemotherapy in ovarian cancer J Clin Oncol 40, 2022 (supply 17; abstr LBA5500)
  15. Surgery Improves Retired Ovarian Cancer Surveillance | Oncology | JAMA | JAMA Network
  16. Wang BL, Liu Z Q, Zou S Q. Netlike Meta analysis of Chinese herbal injection combined with chemotherapy in the treatment of ovarian cancer [J]. Chinese Herbal Medicine and Clinical Pharmacology, 2019, 30 (01):123-130.
  17. Jing Y J, Yang X J, Hao H X. Matrine inhibits proliferation and induces apoptosis of human papillary ovarian carcinoma cells via NF-κB signaling pathway [J]. Chin J Eugenics and Genetics, 2023, 31 (10):2027-2033.
  18. Zhou J H, Li L P, Wang J J et al. Effect of Aidi injection on serum CEA, CA153 and HE4 levels in ovarian cancer model rats [J]. Hebei Medicine, 2019, 41 (10):1490-1493.
  19. PIGNATA S, S C C, DU BOIS A, et al. Treatment of current ovarian cancer [J] Ann Oncol, 2017, 28 (suppl_8): viii51 viii6